Pfizer vaccine appears effective against mutation in new coronavirus variants: Study
The not-yet peer reviewed study by Pfizer and scientists from the University of Texas Medical Branch indicated the vaccine was effective in neutralizing virus with the so-called N501Y mutation of the spike protein.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Coronavirus | COVID-19 | Pfizer | Pharmaceuticals | Study | Texas University | Vaccines